C-type natriuretic peptide co-ordinates cardiac structure and function
Open Access
- 1 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (9) , 1006-1020
Abstract
C-type natriuretic peptide (CNP) is an essential endothelium-derived signalling species that governs vascular homoeostasis; CNP is also expressed in the heart but an intrinsic role for the peptide in cardiac function is not established. Herein, we employ unique transgenic strains with cell-specific deletion of CNP to define a central (patho)physiological capacity of CNP in maintaining heart morphology and contractility. Cardiac structure and function were explored in wild type (WT), cardiomyocyte (cmCNP−/−), endothelium (ecCNP−/−), and fibroblast (fbCNP−/−)—specific CNP knockout mice, and global natriuretic peptide receptor (NPR)-B−/−, and NPR-C−/− animals at baseline and in experimental models of myocardial infarction and heart failure (HF). Endothelium-specific deletion of CNP resulted in impaired coronary responsiveness to endothelium-dependent- and flow-mediated-dilatation; changes mirrored in NPR-C−/− mice. Ex vivo, global ischaemia resulted in larger infarcts and diminished functional recovery in cmCNP−/− and NPR-C−/−, but not ecCNP−/−, vs. WT. The cardiac phenotype of cmCNP−/−, fbCNP−/−, and NPR-C−/− (but not ecCNP−/− or NPR-B−/−) mice was more severe in pressure overload- and sympathetic hyperactivation-induced HF compared with WT; these adverse effects were rescued by pharmacological CNP administration in WT, but not NPR-C−/−, mice. At a molecular level, CNP/NPR-C signalling is impaired in human HF but attenuates activation of well-validated pro-hypertrophic and pro-fibrotic pathways. C-type natriuretic peptide of cardiomyocyte, endothelial and fibroblast origins co-ordinates and preserves cardiac structure, function, and coronary vasoreactivity via activation of NPR-C. Targeting NPR-C may prove an innovative approach to treating HF and ischaemic cardiovascular disorders.Keywords
Funding Information
- British Heart Foundation Programme Grant (RG/16/7/32357, FS/13/58/30648)
- NHLBI Institute of the US
- National Institutes of Health (HL089847, HL105993)
This publication has 46 references indexed in Scilit:
- CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the HeartPLOS ONE, 2012
- Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptorsJournal of Molecular and Cellular Cardiology, 2012
- Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2Basic Research in Cardiology, 2010
- Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac FunctionHypertension, 2009
- Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heartPeptides, 2008
- Pharmacologic Therapies Across the Continuum of Left Ventricular DysfunctionThe American Journal of Cardiology, 2008
- Cardiac production of C-type natriuretic peptide in heart failureJournal of Cardiovascular Medicine, 2006
- Effects of C‐type natriuretic peptide on rat cardiac contractilityBritish Journal of Pharmacology, 1999
- Shear stress induces expression of CNP gene in human endothelial cellsFEBS Letters, 1995
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991